Literature DB >> 28505252

Financing and Distribution of Pharmaceuticals in the United States.

Matan C Dabora1, Namrata Turaga1, Kevin A Schulman2.   

Abstract

Mesh:

Year:  2017        PMID: 28505252     DOI: 10.1001/jama.2017.5607

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Changes in Price for Generic Drugs in the USA, 2008-2016.

Authors:  Chintan V Dave; Gregory Brill; Aaron S Kesselheim
Journal:  J Gen Intern Med       Date:  2019-09       Impact factor: 5.128

Review 2.  Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Authors:  Daniel M Hartung
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.

Authors:  Eric D Shah; Sameer D Saini; William D Chey
Journal:  Clin Gastroenterol Hepatol       Date:  2019-03-01       Impact factor: 11.382

4.  Prescription writing: Generic or brand?

Authors:  Chittaranjan Andrade; T S Sathyanarayana Rao
Journal:  Indian J Psychiatry       Date:  2017 Apr-Jun       Impact factor: 1.759

5.  Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal.

Authors:  Sunil Shrestha; Ramesh Sharma Poudel; Bhuvan Kc; Bhupendra Kumar Poudel; Binaya Sapkota; Sabina Sharma; Anil Khadka
Journal:  J Pharm Policy Pract       Date:  2020-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.